Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharmaceut Sun Pharmaceutical Industries Ltd. | BSE 1675.20 -17.95 (-1.06%) | NSE 1675.50 -17.60 (-1.04%) | Trade | Add

BSE Live

Apr 17, 16:01

1675.20 -17.95 (-1.06%)

Volume

AVERAGE VOLUME

5-Day

197,186

10-Day

191,884

30-Day

143,238

181,661

Prev. Close

1693.15
Open Price

1696.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 17, 15:59

1675.50 -17.60 (-1.04%)

Volume

AVERAGE VOLUME

5-Day

4,677,957

10-Day

4,143,821

30-Day

3,410,357

3,146,482

Prev. Close

1693.10
Open Price

1696.90

Bid Price (Qty.)
1675.50 (442)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	22,625.88	19,843.53	20,394.63	15,518.50	12,570.93
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	22,625.88	19,843.53	20,394.63	15,518.50	12,570.93
Total Operating Revenues	23,003.33	20,275.17	20,812.14	15,585.98	12,803.21
Other Income	369.43	465.76	279.03	957.92	150.22
Total Revenue	23,372.76	20,740.93	21,091.17	16,543.90	12,953.43
EXPENSES
Cost Of Materials Consumed	4,690.67	4,429.38	5,165.63	4,584.97	3,809.11
Purchase Of Stock-In Trade	1,359.53	994.41	1,126.46	1,248.60	1,199.63
Operating And Direct Expenses	0.00	344.45	313.75	275.23	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-69.17	180.32	-237.93	-183.18	-214.84
Employee Benefit Expenses	2,608.26	2,373.95	2,156.95	2,000.78	1,798.45
Finance Costs	893.21	784.08	472.18	388.10	256.98
Depreciation And Amortisation Expenses	1,238.27	1,600.62	1,600.87	1,349.95	586.81
Other Expenses	7,621.42	6,365.05	5,814.42	4,752.06	3,274.86
Total Expenses	18,342.19	17,072.26	16,412.33	14,416.51	10,711.00
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5,030.57	3,668.67	4,678.84	2,127.39	2,242.43
Exceptional Items	0.00	-219.02	-2,937.79	-1,820.53	-89.56
Profit/Loss Before Tax	5,030.57	3,449.65	1,741.05	306.86	2,152.87
Tax Expenses-Continued Operations
Current Tax	908.62	546.10	752.77	-553.58	244.91
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-160.67	45.37	-702.44	960.43	-231.74
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	747.95	591.47	50.33	406.85	13.17
Profit/Loss After Tax And Before ExtraOrdinary Items	4,282.62	2,858.18	1,690.72	-99.99	2,139.70
Profit/Loss From Continuing Operations	4,282.62	2,858.18	1,690.72	-99.99	2,139.70
Profit/Loss For The Period	4,282.62	2,858.18	1,690.72	-99.99	2,139.70
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	17.80	11.90	7.00	-0.40	8.92
Diluted EPS (Rs.)	17.80	11.90	7.00	-0.40	8.92
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	3,613.97	2,898.16	2,519.30	2,158.91	1,559.06
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	1,600.00	1,350.00	1,150.00	1,000.00	750.00